Skip to Content

L020 (Rabeprazole sodium delayed-release 20 mg)

Pill imprint L020 has been identified as Rabeprazole sodium delayed-release 20 mg.

Rabeprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rabeprazole sodium delayed-release 20 mg L020
Rabeprazole sodium delayed-release 20 mg L020
Discount Card Promo
Rabeprazole sodium delayed-release
Imprint:
L020
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Lupin Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide